Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Bhatia

Showing results (71-80 of 220) with videos related to

Pageof 22
Sort By:
Oncotarget|January 14, 2017
Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemiaKaushiki Mukherjee, Xiaojin Sha, Andrew Magimaidas, et al.
The Journal of Biological Chemistry|December 17, 2009
BCR-ABL gene expression is required for its mutations in a novel KCL-22 cell culture model for acquired resistance of chronic myelogenous leukemiaHongfeng Yuan, Zhiqiang Wang, Chunggang Gao, et al.
Cell Reports|July 14, 2021
TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signalingPuneet Agarwal, Hui Li, Kwangmin Choi, et al.
Blood|September 4, 2004
Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatmentSu Chu, Helen Xu, Neil P Shah, et al.
Blood|January 10, 2013
Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signalingBin Zhang, Min Li, Tinisha McDonald, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 20, 2008
Impact of diabetes and acute coronary syndrome on survival in patients treated with drug-eluting stentsMichael S Lee, Daniel Jurewitz, Raymond Zimmer, et al.
Cancer Cell|February 21, 2012
Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinibLing Li, Lisheng Wang, Liang Li, et al.
Ejhaem|June 19, 2024
Low-dose decitabine plus venetoclax as post-transplant maintenance for high-risk myeloid malignanciesKatherine Parks, Kendall Diebold, Donna Salzman, et al.
Leukemia Research|August 1, 2006
Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic cloneVinod Pullarkat, Victoria Bedell, Young Kim, et al.
Bone Marrow Transplantation|April 3, 2023
Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemiaOmer Jamy, Kendall Diebold, Kenneth Davis, et al.
Pageof 22

Showing results (71-80 of 220) with videos related to

Sort By:
Pageof 22
Oncotarget|January 14, 2017
Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemiaKaushiki Mukherjee, Xiaojin Sha, Andrew Magimaidas, et al.
The Journal of Biological Chemistry|December 17, 2009
BCR-ABL gene expression is required for its mutations in a novel KCL-22 cell culture model for acquired resistance of chronic myelogenous leukemiaHongfeng Yuan, Zhiqiang Wang, Chunggang Gao, et al.
Cell Reports|July 14, 2021
TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signalingPuneet Agarwal, Hui Li, Kwangmin Choi, et al.
Blood|September 4, 2004
Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatmentSu Chu, Helen Xu, Neil P Shah, et al.
Blood|January 10, 2013
Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signalingBin Zhang, Min Li, Tinisha McDonald, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 20, 2008
Impact of diabetes and acute coronary syndrome on survival in patients treated with drug-eluting stentsMichael S Lee, Daniel Jurewitz, Raymond Zimmer, et al.
Cancer Cell|February 21, 2012
Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinibLing Li, Lisheng Wang, Liang Li, et al.
Ejhaem|June 19, 2024
Low-dose decitabine plus venetoclax as post-transplant maintenance for high-risk myeloid malignanciesKatherine Parks, Kendall Diebold, Donna Salzman, et al.
Leukemia Research|August 1, 2006
Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic cloneVinod Pullarkat, Victoria Bedell, Young Kim, et al.
Bone Marrow Transplantation|April 3, 2023
Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemiaOmer Jamy, Kendall Diebold, Kenneth Davis, et al.
Pageof 22